Co-Authors
This is a "connection" page, showing publications co-authored by AMIR A JAZAERI and RAGHUNANDAN VIKRAM.
Connection Strength
0.234
-
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer. 2024 04 01; 130(7):1061-1071.
Score: 0.234
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.